Beam Therapeutics Inc. Balance Sheet
BEAM / Health Care|7 years of annual SEC 10-K data (FY2019-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
Beam Therapeutics Inc. had $1.5B in total assets and $1.2B in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $294.9M | $282.0M | $435.9M | $232.8M | $560.0M | $37.2M | $37.2M |
| Current Assets | $1.3B | $878.1M | $1.2B | $1.1B | $1.3B | $308.3M | $94.5M |
| PP&E (Net) | $104.5M | $111.4M | $125.0M | $115.6M | $84.3M | $38.5M | $24.3M |
| Total Assets | $1.5B | $1.1B | $1.5B | $1.3B | $1.5B | $451.7M | $156.1M |
| Current Liabilities | $96.9M | $182.1M | $205.6M | $223.6M | $213.4M | $102.3M | $29.1M |
| Shareholders' Equity | $1.2B | $733.5M | $981.3M | $733.5M | $826.7M | -$117.4M | -$201.1M |